Using neuroimaging to evaluate and guide pharmacological and psychotherapeutic treatments for mood disorders in children

CNS Spectr. 2015 Aug;20(4):359-68. doi: 10.1017/S1092852914000819. Epub 2015 Feb 9.

Abstract

Mood disorders are increasing in childhood, and often require multimodal and comprehensive treatment plans to address a complex array of symptoms and associated morbidities. Pharmacotherapy, in combination with psychotherapeutic interventions, is essential for treatment and stabilization. Current evidence supports the use of a number of interventions in children and adolescents diagnosed with DSM-5 mood spectrum disorders, which are associated with impairments in prefrontal-striatal-limbic networks, which are key for emotional functioning and regulation. Yet, little is known about the neurobiological effects of interventions on the developing brain. This chapter provides a synopsis of the literature demonstrating the neural effects of psychotropic medications and psychotherapy in youth with depressive or bipolar spectrum disorders. Additional longitudinal and biological studies are warranted to characterize the effects of these interventions on all phases and stages of mood illness development in children and adolescents.

Keywords: Bipolar disorder; MRI; depression; intervention; neuroimaging; pediatric.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Bipolar Disorder / diagnosis
  • Bipolar Disorder / drug therapy
  • Bipolar Disorder / physiopathology*
  • Bipolar Disorder / therapy
  • Brain / growth & development
  • Brain / physiopathology*
  • Child
  • Depression / diagnosis
  • Depression / drug therapy
  • Depression / physiopathology*
  • Depression / therapy
  • Humans
  • Neuroimaging*
  • Psychotherapy*
  • Psychotropic Drugs / pharmacology*

Substances

  • Psychotropic Drugs